Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac | MicrobiomeTrials← Back to trialsNCT07733219
Multicentre Phase II Trial Evaluating Stereotactic Body Radiotherapy on Ultra-central Lung Tumors on MR-Linac
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2031-11-01
Enrollment target: 59 participants ContactFlorence LE TINIER, MD
Other microbiome trials you might be interested in
Lung Cancer
MAGELLAN is a phase-I dose escalation trial that aims to identify the maximum tolerated dose (MTD) of MR-guided SBRT of …
Heidelberg, GermanyEst. completion Nov 1, 2030
Non Small Cell Lung Cancer
This multi-centre phase I dose-escalation study will use a time-to-event continual reassessment method (TIT-CRM).
Accru…
Vancouver, CanadaEst. completion Apr 19, 2021